Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of bevantolol on sexual function in young and middle-aged men with hypertension
ChiCTR2200062201Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Henan University of Chinese Medicine
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevantolol in essential hypertension, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoint: Change in IIEF-5 score. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
bevantolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR2200062201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062201.